-
Webinar: Deepen your knowledge on comprehensive genomic profiling
Join our educational webinar on comprehensive genomic profiling on Wednesday, October 5 at 6:00 PM CEST, to find out how your cancer patient can benefit from biomarker testing. Register for free https://event.on24.com/wcc/r/3923804/7192787FC3EE75423B64180F985FE7B5
-
Product Owner for Clinical Decision Support Software (m/f/d)
This position combines software specifications, UI, and UX work – if you are interested in working as product owner of a scrum team creating software products that improve patient’s lives, you are welcome at Molecular Health.
-
MH Guide Webinar – 07.06.2022 12:00 am EST
Join our free-to-attend Live Webinar showcasing how MH Guide translates genomic tumor data into clinical evidence in a few minutes.
-
MH Guide 5.2 – Improved focus. Greater flexibility. Better usability.
When it comes to targeted cancer treatments, new biomarkers are continually found, and additional treatment options are approved. Keeping pace with those changes with MH Guide 5.2.
-
MH Guide Webinar – 28.04.2022 5:00 pm CET
Join our free-to-attend Live Webinar showcasing how to automatically identify clinically actionable biomarkers in molecular tumor profiles of individual patients.
-
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ2 published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD).
-
What’s new in MH Guide 5.1
The MH Guide 5.1 upgrade introduces new features and improved capabilities to access more information and make therapy decisions clearer.
-
GENOPATH GbR
With head offices in Bonn, Germany, GENOPATH GbR is an association of 16 pathology institutes. The group formed to supply all member laboratories with top-quality and cutting-edge molecular diagnostic services that complement existing histological and cytological methods, making the comprehensive care available to every cancer patient.
-
MH Guide: Molecular tumor diagnostics in 7 steps
The MH Guide software claims to support therapy decisions in oncology. It can translate data obtained from molecular tumor diagnostic tests into clinically relevant knowledge. This overview illustrates the practical use of the MH Guide.
-
Panel diagnostics instead of hotspot? Here are the differences
NGS, WGS, SNV – What do these abbreviations stand for in molecular pathological diagnostics? What are the benefits of NGS-based panel diagnostics in oncology? This overview provides answers regarding methods of molecular tumor diagnostic testing.